ArticleOncolytic virotherapy2015

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor-resistant multiple myeloma.

Katherine M Dunlap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.